Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03810105
Title A Study of Olaparib and Durvalumab in Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

prostate cancer

Therapies

Durvalumab + Olaparib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST